Koninklijke Philips (RYLPF) Interest & Investment Income (2009 - 2026)
Koninklijke Philips (RYLPF) recorded quarterly Interest & Investment Income of $41.0 million in Q1 2026, down 53.27% quarter-over-quarter from $87.7 million in Q3 2025, and up 18.05% on a YoY basis from $34.7 million in Q1 2025.
Koninklijke Philips (RYLPF) Interest & Investment Income (2009 - 2026) Analysis & Trends
Koninklijke Philips' Interest & Investment Income history runs 18 years deep, the most recent figure standing at $41.0 million for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 18.05% year-over-year to $41.0 million; the TTM figure through Mar 2026 stood at $41.0 million (up 18.05% YoY), while the FY2025 annual figure was $131.5 million, up 17.23% from the prior year.
- Interest & Investment Income was $41.0 million for Q1 2026 at Koninklijke Philips, down from $87.7 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $87.7 million in Q3 2025 to a low of -$62.6 million in Q3 2024.
- Historically, Interest & Investment Income has averaged $14.0 million across 5 years, with a median of $19.1 million in 2022.
- Biggest YoY gain for Interest & Investment Income was 334.22% in 2024; the steepest drop was 251.82% in 2024.
- A 5-year view of Interest & Investment Income shows it stood at $60.5 million in 2022, then decreased by 17.23% to $50.1 million in 2023, then slumped by 225.01% to -$62.6 million in 2024, then jumped by 240.07% to $87.7 million in 2025, then sank by 53.27% to $41.0 million in 2026.
- The last three Interest & Investment Income figures came in at $41.0 million (Q1 2026), $87.7 million (Q3 2025), and -$49.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 33.50 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | - |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 40.98 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Koninklijke Philips | - | - | 2.07 Bn | 40.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.98 Mn |
| Sep 30, 2025 | 87.68 Mn |
| Jun 30, 2025 | -49.81 Mn |
| Mar 31, 2025 | 34.71 Mn |
| Sep 30, 2024 | -62.60 Mn |
| Jun 30, 2024 | 48.46 Mn |
| Mar 31, 2024 | -22.81 Mn |
| Sep 30, 2023 | 50.08 Mn |
| Jun 30, 2023 | -20.69 Mn |
| Mar 31, 2023 | 15.03 Mn |
| Sep 30, 2022 | 60.50 Mn |
| Jun 30, 2022 | -18.14 Mn |
| Mar 31, 2022 | 19.08 Mn |
| Dec 31, 2021 | -20.59 Mn |
| Sep 30, 2021 | 134.44 Mn |
| Jun 30, 2021 | 90.32 Mn |
| Mar 31, 2021 | 43.42 Mn |
| Dec 31, 2020 | 188.38 Mn |
| Sep 30, 2020 | 148.35 Mn |
| Jun 30, 2020 | 105.74 Mn |